BioHealth News Archive
How Quantum Computing Will Change Everything (with Chad Rigetti)
Quantum computing won’t be an incremental improvement – it will be a step-change in the power of the technology that underpins a huge part…
Read MoreNovavax COVID-19 Vaccine Found to be Safe and Effective in Phase 3 Trial Conducted by UM School of Medicine Researchers
Research Shows Vaccine Has 90 Percent Efficacy at Preventing Infections; Moderate to Severe Disease Occurred Only in Placebo Recipients An investigational COVID-19 vaccine made…
Read MoreEmergent BioSolutions Announces Initiation of Phase 1 Study Evaluating Its Universal Influenza Vaccine Candidate
GAITHERSBURG, Md., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the first participant dosed in its phase 1 study,…
Read MoreZalgen Relocates Headquarters to Life Sciences Epicenter in Frederick, Maryland
Frederick, MD, December 16, 2021 – One of the leading biotechnology and diagnostics companies in the field of neglected viral diseases with pandemic potential…
Read MoreVT Corporate Research Center Receives GO Virginia Grant to Expand Lab Facilities and Resources | VT Corporate Research Center
New collaboration with Johnson & Johnson Innovation announced with the aim to accelerate life science sector growth in the New River and Roanoke Valleys…
Read More$1.1M Grant from GO Virginia Coalition Advancing Biotech at the Virginia Tech Corporate Research Center (VTCRC)
BLACKSBURG, Va. (WDBJ) - “Just watch, we’ve got some great things coming,” Virginia Tech Corporate Research Center President and CEO, Brett Malone said as…
Read MoreVaccitech acquires Avidea Technologies to expand product
OXFORD, United Kingdom, and BALTIMORE, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and…
Read MorePrestigious annual pediatric medical device competition takes aim at congenital heart disease with five innovators sharing $150K in NCC-PDI grants · BioBuzz
Washington D.C., Dec. 10, 2021 (GLOBE NEWSWIRE) — The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces five awardees chosen in its prestigious annual “Make…
Read MoreHHS Secretary Becerra Names Dr. Lawrence Tabak Acting Director of NIH | HHS.gov
Health and Human Services Secretary Xavier Becerra today announced that Lawrence A. Tabak, D.D.S., Ph.D., the principal deputy director of the National Institutes of…
Read MoreWBJ – Novavax’s Campus Expansion Plans Earn Green Light in Gaithersburg
Novavax Inc. (NASDAQ: NVAX) just earned a critical approval to expand its Gaithersburg campus, paving the way for the homegrown biotech to exponentially grow its local…
Read MoreCCP’s largest project awarded $204 million extension through July 2025 | Hub
The United States Agency for International Development has awarded a $204 million extension to the Johns Hopkins Center for Communication Programs to continue Breakthrough…
Read MoreGlobal pandemic center will be in Rockville medical office building
A global center focusing on pandemic prevention and biodefense work will be in Rockville, county officials and partners in the project said Wednesday. Connected…
Read MoreHarnessing the power of monoclonal antibodies in virology
Monoclonal antibodies have become one of humanity’s most powerful, multi-use tools in biology and medicine. Once the field of immunology established that they could…
Read MoreEvusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the pre-exposure prophylaxis…
Read MoreSupernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
ROCKVILLE, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company focused on developing and commercializing products for the…
Read More